Grants for State governments - Health

This funding opportunity supports innovative research projects aimed at developing tools and treatments for diagnosing and mitigating injuries from radiation exposure during public health emergencies.

The ODAC Grant Program, part of the SFY 2025 initiative by the Governor's Office of Crime Prevention and Policy, is designed to decrease the number of fatal and non-fatal overdoses stemming from substance use. The program emphasizes the coordination of law enforcement and public health efforts to combat the substance abuse epidemic through enhanced investigative strategies, data sharing, and community outreach. The ODAC initiative aligns with the state's goals to improve public health and safety by addressing the root causes of drug abuse and facilitating access to treatment and support services.

This funding opportunity supports non-profit organizations in New York City and Northeastern New Jersey that focus on innovative programs in social welfare, education, and healthcare, particularly for youth in underserved communities.

This funding opportunity announcement (FOA) encourages innovative research to develop, characterize, and improve animal models, biological materials, and novel technologies to better understand human health and disease. This FOA also seeks projects aimed at improving the diagnosis and control of diseases that interfere with animal use for biomedical research. The proposed project must have broad application to multiple NIH Institutes or Centers (ICs) to align with the Office of Research Infrastructure Programs (ORIP) trans-NIH mission. The proposed studies must explore multiple body systems or evaluate diseases that impact multiple body systems. Applications that develop models focused on a specific disease or area of research, or only propose studies primarily relevant to a single NIH IC will be considered not acceptable to this FOA.

This funding opportunity provides financial support to nursing schools and organizations to increase the number of registered nurses from disadvantaged backgrounds, enhancing educational pathways and resources for students in underserved communities.

This funding opportunity supports early-career clinical researchers in the U.S. to develop expertise in implementation science for substance use prevention and treatment through mentored clinical trials addressing the overdose crisis.

The "Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network" grant is a $3.8 million funding opportunity from the National Institutes of Health, specifically for Queen’s University at Kingston, to support its collaboration with the U.S. in conducting large-scale, multi-site clinical trials for innovative cancer treatments, while ensuring regulatory compliance and efficient data management.

This funding opportunity provides financial support for researchers to build on existing studies and resources to advance the understanding and treatment of post-traumatic epilepsy, particularly benefiting Service Members, Veterans, and their families.

The "Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dementias (ADRD)" grant aims to fund the creation and testing of new, complex human cell models that accurately represent Alzheimer's and related dementias, with the goal of improving our understanding of these diseases and aiding in the development of potential therapies.

This grant provides funding for educational programs that improve the skills and knowledge of researchers analyzing large, complex datasets related to brain function, behavior, and social factors affecting health outcomes.

This funding opportunity provides financial support to a wide range of organizations, including governments, educational institutions, and nonprofits, to increase awareness and improve public health responses to Alpha-gal Syndrome, a tick-borne allergy affecting reactions to mammalian meat.

This funding opportunity is designed to help health centers improve access to dental care for children with neurodevelopmental disorders, such as autism, by implementing innovative strategies and enhancing workforce training.

This funding opportunity provides support for clinical researchers to develop independent careers in patient-centered and comparative effectiveness research, focusing on improving healthcare delivery for underserved populations in the U.S.

This funding opportunity supports innovative, time-sensitive research projects that enhance ongoing clinical studies related to arthritis, musculoskeletal, and skin diseases by leveraging existing patient data and samples.

This funding opportunity supports established biomedical data repositories and knowledgebases to enhance their operations and community engagement, ensuring they remain vital resources for researchers in the biomedical field.

This funding opportunity provides financial support for a centralized coordination center that will ethically manage and enhance research on ancient human DNA, fostering collaboration among diverse scientific and community stakeholders.

This funding opportunity supports research that develops innovative tools to measure and enhance children's language development, particularly by engaging diverse communities and understanding environmental influences.

This funding opportunity supports community-based organizations in the Mid-Atlantic region to implement sustainable forestry initiatives that promote environmental justice, improve public health, and create green job opportunities in disadvantaged areas.

This funding opportunity provides financial support for researchers developing innovative, non-opioid treatments for various types of pain, with a focus on early-stage studies and collaboration with underrepresented populations.

Grant Title: New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed) aims to fund innovative research to develop new treatments for genital herpes that can reduce viral shedding, prevent lesions, and lower transmission risks.